As the IGF and insulin signaling axes have a crucial role in EAC cell proliferation and cancer progression, targeting IGF-IR/IR might therefore be an encouraging anticancer therapeutic path for EAC [24,27]. This evidence concerns the gene IGF1 and cancer.